bismuth has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imura, N; Kawamura, E; Matsuzaki, N; Miura, N; Naganuma, A; Satoh, M | 1 |
| Imura, N; Naganuma, A; Satoh, M | 1 |
2 other study(ies) available for bismuth and Leukemia P388
| Article | Year |
|---|---|
Prevention of adverse effects of gamma-ray irradiation after metallothionein induction by bismuth subnitrate in mice.
Topics: Adenocarcinoma; Animals; Bismuth; Bone Marrow; Colonic Neoplasms; Gamma Rays; Leukemia P388; Male; Metallothionein; Mice; Mice, Inbred Strains; Radiation Injuries, Experimental; Radiation, Ionizing | 1989 |
Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Topics: Animals; Antacids; Bismuth; Cisplatin; Digestive System; Kidney; Leukemia P388; Male; Metallothionein; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL | 1987 |